Phase I trial of CJRB-101 plus pembrolizumab in patients with metastatic non-small cell lung cancer, head and neck squamous cell carcinoma and melanoma
Phase I trial of CJRB-101 plus pembrolizumab in patients with metastatic non-small cell lung cancer, head and neck squamous cell carcinoma and melanoma
J. Immunother. Cancer, DOI: 10.1136/jitc-2025-014702
Social Capital and Financial Toxicity in Caregivers of Patients With Advanced Cancer: Associations With Health-Related Quality of Life and Psychological Distress
Social Capital and Financial Toxicity in Caregivers of Patients With Advanced Cancer: Associations With Health-Related Quality of Life and Psychological Distress
J. Natl. Compr. Cancer Netw., DOI: 10.6004/jnccn.2025.7141
Multiscale molecular modeling–directed ROS-responsive nanotherapy for dual-axis regulation of fibrotic and inflammatory signaling in alport nephropathy
Multiscale molecular modeling–directed ROS-responsive nanotherapy for dual-axis regulation of fibrotic and inflammatory signaling in alport nephropathy
J. Nanobiotechnol., DOI: 10.1186/s12951-026-04451-w
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer
Comprehensive Chemoproteomics Unveils Selective HMG-CoA Synthase 1 Inhibitors for Targeting Mevalonate Metabolism in Cancer
Comprehensive Chemoproteomics Unveils Selective HMG-CoA Synthase 1 Inhibitors for Targeting Mevalonate Metabolism in Cancer